A 2023 ocva.eu study reveals frozen konjac glucomannan reduces visceral fat by 18% and improves insulin sensitivity in obese mice, outperforming sol and gel forms through enhanced prebiotic effects. R...
New research demonstrates konjac glucomannan gel forms enhance Akkermansia microbiota and improve metabolic markers in obese mice, with implications for personalized human nutrition strategies. A 2024...
New clinical studies demonstrate konjac glucomannan’s ability to lower LDL cholesterol and fasting glucose while enhancing gut microbiota diversity, offering a novel dietary strategy for metabol...
Recent studies and tech innovations demonstrate how mindful eating improves glycemic control and digestion, endorsed by ADA guidelines and supported by AI-powered tracking tools. The American Diabetes...
New research reveals konjac glucomannan’s significant effects on glucose metabolism and gut microbiota, offering promising solutions for obesity management. Groundbreaking studies demonstrate ko...
Recent study reveals KGM’s benefits on glucose, lipid metabolism, and gut microbiota in obese mice, with potential applications for human metabolic health. New research highlights konjac glucoma...
New research reveals konjac glucomannan’s unique ability to modulate gut microbiota and improve metabolic markers through different intake forms, offering novel obesity management strategies. Cu...
New research highlights konjac glucomannan’s potential in weight management and metabolic health through gut microbiota modulation and SCFA production. Recent studies demonstrate konjac glucoman...
Recent studies demonstrate konjac glucomannan’s effectiveness in improving glucose and lipid metabolism, with novel gel forms showing enhanced benefits for obese individuals. Emerging research r...
Recent studies highlight KGM’s effectiveness in weight control and metabolic regulation through gut microbiota modulation and SCFA production. New research demonstrates konjac glucomannan’...
